EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A Molecular Tool Set for Measurement of Lung Cancer-Associated Protein Biomarker CIZ1B-FibA in Human Plasma

Susanna F Rose, Joanna F Pearson, Lewis Byrom, Justin F X Ainscough, Dawn Coverley

The Journal of Applied Laboratory Medicine · 2026-11-04 · 11 (6) · 1463-1477

DOI: 10.1093/jalm/jfag124 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background CIZ1B is an alternatively spliced protein fragment of the Cyclin-dependent kinase interacting protein 1 (CIP1)-interacting zinc finger protein (CIZ1) complexed with fibrinogen alpha chain (FibA), forming a single parameter protein analyte (CIZ1B-FibA). The CIZ1B blood biomarker has potential to indicate the presence of early-stage lung cancer and could alter clinical practice. Methods We report configuration and calibration of a sandwich ELISA for measurement of CIZ1B-FibA that uses a new and highly specific CIZ1B exon junction-selective monoclonal antibody to capture the analyte, and an anti-fibrinogen antibody to detect it, in microliter quantities of plasma from lung cancer patients. Results The format is tested across 3 independent sample sets encompassing cancer and control samples, yielding Receiver Operating Characteristic area under curve (ROC AUC) values of 0.82 for Set 1 (n = 48), 0.81 for Set 2 (n = 38), and 0.86 for Set 3 (n = 57), indicating discrimination for individuals with lung cancer including those with stage I or II disease (Set 3). However, comparison of the control plasma samples in each set, which were sourced in 3 countries with site-specific plasma isolation processes, revealed baseline differences indicating a note of caution regarding sensitivity to pre-analytic variables. Application of set-specific thresholds, determined by the maximum Youden Index, returned negative predictive values (NPV) of 95%, 77%, and 97% for Sets 1, 2 and 3, respectively. Conclusion We describe an affordable and scalable blood test which can measure CIZ1B-FibA and now requires further validation of analytical parameters and investigation of potential biological variables.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →